We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CSAN:NYSECosan S.A. Analysis

Data as of 2026-03-27 - not real-time

$4.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Cosan is trading well below its discounted cash‑flow estimate, suggesting a substantial valuation gap. The stock sits under the 20‑day and 50‑day moving averages, while a bearish MACD crossover and a mid‑range RSI point to continued downside pressure. Volume is rising, but the 30‑day volatility remains high, reflecting an unsettled market. Recent headlines confirm a hefty quarterly loss and a sizable debt load, although the company has trimmed debt by nearly half and is discussing a multi‑hundred‑million‑dollar capital injection with its joint‑venture partner. Forward earnings are projected to turn positive, and the firm’s diversified energy and logistics assets provide a strategic foothold in Brazil’s biofuel and natural‑gas markets. Nonetheless, negative profit margins, a negative free‑cash‑flow position, and a high price‑to‑book multiple raise concerns about near‑term profitability. Given the blend of deep undervaluation, ongoing restructuring, and elevated risk factors, the outlook hinges on execution of debt reduction and cash‑generation initiatives.
Investors should weigh the upside potential against the company’s fragile earnings profile and sector‑specific regulatory headwinds. The current technical picture is bearish, but the fundamental narrative offers a value‑oriented case if the turnaround gains traction. A cautious stance is warranted, with a focus on monitoring cash flow trends, debt servicing capacity, and any further strategic capital infusions.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 4/10

Key Factors

  • Bearish technical indicators (price below short‑term averages, negative MACD)
  • High short‑term volatility and recent large quarterly loss
  • Support level near current price limiting downside

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Significant valuation gap versus DCF fair value
  • Debt reduction progress and upcoming JV capital injection
  • Forward earnings expected to turn positive

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Strategic exposure to Brazil’s growing biofuel and natural‑gas sectors
  • Diversified logistics and energy assets providing resilient cash streams
  • Long‑term undervaluation relative to intrinsic worth if turnaround succeeds

Key Metrics & Analysis

Financial Health

Revenue Growth-18.30%
Profit Margin-24.05%
P/E Ratio16.1
ROE-28.96%
ROA4.84%
Debt/Equity227.80
P/B Ratio15.6
Op. Cash Flow$13.0B
Free Cash Flow$-3686907136
Industry P/E23.6

Technical Analysis

TrendBearish
RSI41.2
Support$3.83
Resistance$5.17
MA 20$4.31
MA 50$4.47
MA 200$4.59
MACDBearish
VolumeIncreasing
Fear & Greed Index72.43

Valuation

Fair Value$83.92
Target Price$4.98
Upside/Downside24.51%
GradeUndervalued
TypeValue

Risk Assessment

Beta0.91
Volatility61.33%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.